Zevra Therapeutics, Inc. Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (2 lists). Names and jurisdictions are as filed.
- 2026-03-09: Subsidiary Document.
- 2026-03-09: Subsidiary Acer Therapeutics Inc.; Jurisdiction Delaware.
- 2026-03-09: Subsidiary Zevra Denmark A/S; Jurisdiction Denmark.
- 2024-04-01: Subsidiary Acer Therapeutics Inc.; Jurisdiction United States.
| Annual report filed | Subsidiary | Jurisdiction |
|---|---|---|
| 2026-03-09 | Document | |
| 2026-03-09 | Acer Therapeutics Inc. | Delaware |
| 2026-03-09 | Zevra Denmark A/S | Denmark |
| 2024-04-01 | Acer Therapeutics Inc. | United States |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |